Viewing Study NCT04044560

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:07 AM
Ignite Modification Date: 2026-02-03 @ 6:02 AM
Study NCT ID: NCT04044560
Status: TERMINATED
Last Update Posted: 2022-02-21
First Post: 2019-07-31
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Blinatumomab for MRD in Pre-B ALL Patients Following Stem Cell Transplant
Sponsor: University of British Columbia
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B-cell Adult Acute Lymphoblastic Leukemia View
None Stem Cell Leukemia View
None Minimal Residual Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None acute lymphoblastic leukemia, blinatumomab, minimal residual disease, stem cell transplant View